Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
27.85
-0.52 (-1.83%)
Mar 3, 2026, 4:00 PM EST - Market closed
Rapport Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Rapport Therapeutics stock have an average target of 47, with a low estimate of 28 and a high estimate of 80. The average target predicts an increase of 68.76% from the current stock price of 27.85.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for Rapport Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $43 | Buy | Initiates | $43 | +54.40% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $40 | Strong Buy | Maintains | $34 → $40 | +43.63% | Dec 9, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +68.76% | Dec 8, 2025 |
| BTIG | BTIG | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +68.76% | Nov 19, 2025 |
| Citizens | Citizens | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | +187.25% | Nov 7, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.88
from -3.78
EPS Next Year
-3.60
from -2.88
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.82 | -2.55 | ||||
| Avg | -2.88 | -3.60 | ||||
| Low | -2.94 | -4.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.